ANIP insider transactions
ANI Pharmaceuticals Inc. (ANIP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
ANIP insiders
Everyone who has filed a Form 3, 4, 5 or 144 at ANI Pharmaceuticals Inc., latest first. Follow anyone to get their next filing.
- Stephen P. CareySVP & CFO-$8.62M
- Nikhil LalwaniPresident & CEO, Director+$200K-$20M
- Meredith CookSr. VP, General Counsel & Sec., since July 2022-$898K
- Jeanne ThomaDirector+$99.6K-$1.99M
- Henry O GosebruchDirector, since August 2026
- Ori GutwergSVP, Generics, since February 2021-$2.68M
- Patrick D WalshDirector+$270K-$3.12M
- Renee P TannenbaumDirector, since March 2022-$274K
- Antonio R PeraDirector+$127K-$1.82M
- Matthew J LeonardDirector, since August 2023-$841K
- Thomas HaugheyDirector+$98.5K-$1.82M
- Thomas Andrew RowlandSVP, Head - Established Brands, since March 2024-$820K
- Christopher MutzHead of Rare Disease, since February 2021-$2.86M
- Krista DavisSVP, Chief Hr Officer, since September 2022-$1.62M
- Muthusamy ShanmugamHead of R&d, COO-Novitium Ops, Director, since November 2021+$277K-$63.3M
- Chad GassertSVP - Corp. Dev. & Strategy, since November 2021+$275K-$15.1M
- James G. MarkenSVP Ops & Prod Dev-$2.54M
- Meridian Venture Partners Ii LP10% owner-$19.4M
- David NashDirector
- Robert E. Brown JRDirector
- Robert W SchrepferOfficer
Recent Form 3, 4, and 5 filings for ANIP
- SVP & CFO Carey Stephen P. sold $207,680 worth of shares (2,850 units at $72.87) as part of a pre-agreed trading plan (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- PRESIDENT & CEO Lalwani Nikhil sold $388,206 worth of shares (5,400 units at $71.89) as part of a pre-agreed trading plan (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SR. VP, GENERAL COUNSEL & SEC. Cook Meredith sold $36,795 worth of shares (500 units at $73.59) as part of a pre-agreed trading plan (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP & CFO Carey Stephen P. sold $208,050 worth of shares (2,850 units at $73.00) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 168,993 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- PRESIDENT & CEO Lalwani Nikhil sold $383,400 worth of shares (5,400 units at $71.00) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 339,089 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- Director Thoma Jeanne sold $71,530 worth of shares (1,000 units at $71.53) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 26,762 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SR. VP, GENERAL COUNSEL & SEC. Cook Meredith sold $35,395 worth of shares (500 units at $70.79) as part of a pre-agreed trading plan, decreasing direct ownership by 0.67% to 73,924 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP & CFO Carey Stephen P. sold $207,480 worth of shares (2,850 units at $72.80) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 171,843 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- Director Gosebruch Henry O was granted 6,662 shares (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SEC Form 3 filed by new insider Gosebruch Henry O3 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- PRESIDENT & CEO Lalwani Nikhil sold $401,220 worth of shares (5,400 units at $74.30) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 344,489 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SR. VP, GENERAL COUNSEL & SEC. Cook Meredith sold $37,740 worth of shares (500 units at $75.48) as part of a pre-agreed trading plan, decreasing direct ownership by 0.67% to 74,424 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, GENERICS Gutwerg Ori sold $243,474 worth of shares (3,162 units at $77.00), decreasing direct ownership by 4% to 75,534 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP & CFO Carey Stephen P. sold $231,876 worth of shares (2,850 units at $81.36) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 174,693 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SR. VP, GENERAL COUNSEL & SEC. Cook Meredith covered exercise/tax liability with 2,466 shares, decreasing direct ownership by 3% to 74,924 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SR. VP, GENERAL COUNSEL & SEC. Cook Meredith sold $40,920 worth of shares (500 units at $81.84) as part of a pre-agreed trading plan, decreasing direct ownership by 0.64% to 77,390 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP & CFO Carey Stephen P. exercised 3,313 shares at a strike of $49.51 and sold $284,918 worth of shares (3,313 units at $86.00) as part of a pre-agreed trading plan (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP & CFO Carey Stephen P. sold $239,742 worth of shares (2,850 units at $84.12) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 177,543 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SR. VP, GENERAL COUNSEL & SEC. Cook Meredith sold $41,015 worth of shares (500 units at $82.03) as part of a pre-agreed trading plan, decreasing direct ownership by 0.64% to 77,890 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- Director Thoma Jeanne was granted 4,357 shares, increasing direct ownership by 19% to 27,762 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- Director Tannenbaum Renee P was granted 4,357 shares, increasing direct ownership by 17% to 29,514 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- Director Pera Antonio R was granted 4,357 shares, increasing direct ownership by 19% to 27,017 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- Director Leonard Matthew J was granted 4,357 shares, increasing direct ownership by 63% to 11,221 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- Director Haughey Thomas was granted 4,357 shares and sold $161,760 worth of shares (2,000 units at $80.88) as part of a pre-agreed trading plan, increasing direct ownership by 6% to 38,878 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP & CFO Carey Stephen P. exercised 3,312 shares at a strike of $49.51 and sold $264,960 worth of shares (3,312 units at $80.00) as part of a pre-agreed trading plan (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- Director Walsh Patrick D sold $1,127,120 worth of shares (13,973 units at $80.66), decreasing direct ownership by 27% to 38,432 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, HEAD - ESTABLISHED BRANDS Rowland Thomas Andrew sold $36,357 worth of shares (459 units at $79.21), decreasing direct ownership by 1% to 38,271 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- PRESIDENT & CEO Lalwani Nikhil sold $4,266,350 worth of shares (55,000 units at $77.57), decreasing direct ownership by 14% to 349,889 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, GENERICS Gutwerg Ori sold $220,374 worth of shares (2,772 units at $79.50), decreasing direct ownership by 3% to 78,696 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SR. VP, GENERAL COUNSEL & SEC. Cook Meredith sold $39,080 worth of shares (500 units at $78.16) as part of a pre-agreed trading plan, decreasing direct ownership by 0.63% to 78,390 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SEC Form 4 filed by Cook Meredith4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- HEAD OF RARE DISEASE Mutz Christopher sold $226,526 worth of shares (3,162 units at $71.64), decreasing direct ownership by 3% to 91,309 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, HEAD - ESTABLISHED BRANDS Rowland Thomas Andrew sold $357,471 worth of shares (4,772 units at $74.91), decreasing direct ownership by 11% to 38,730 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SR. VP, GENERAL COUNSEL & SEC. Cook Meredith sold $36,310 worth of shares (500 units at $72.62), decreasing direct ownership by 0.63% to 79,390 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- HEAD OF RARE DISEASE Mutz Christopher sold $424,617 worth of shares (5,723 units at $74.19) and covered exercise/tax liability with 3,314 shares, decreasing direct ownership by 9% to 94,471 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- PRESIDENT & CEO Lalwani Nikhil covered exercise/tax liability with 17,060 shares, decreasing direct ownership by 4% to 404,889 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, GENERICS Gutwerg Ori covered exercise/tax liability with 3,314 shares, decreasing direct ownership by 4% to 81,468 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, CHIEF HR OFFICER Davis Krista sold $488,474 worth of shares (6,572 units at $74.33), decreasing direct ownership by 11% to 51,946 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP & CFO Carey Stephen P. covered exercise/tax liability with 5,150 shares, decreasing direct ownership by 3% to 180,393 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP & CFO Carey Stephen P. exercised 3,312 shares at a strike of $49.51 and sold $552,031 worth of shares (7,312 units at $75.50), decreasing direct ownership by 2% to 185,543 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- HEAD OF RARE DISEASE Mutz Christopher sold $30,858 worth of shares (417 units at $74.00), decreasing direct ownership by 0.40% to 103,508 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, GENERICS Gutwerg Ori sold $157,590 worth of shares (2,060 units at $76.50), decreasing direct ownership by 2% to 84,782 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- Director Walsh Patrick D sold $445,380 worth of shares (6,000 units at $74.23), decreasing direct ownership by 10% to 52,405 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- HEAD OF R&D, COO-NOVITIUM OPS Shanmugam Muthusamy was granted 11,116 shares, increasing direct ownership by 12% to 101,056 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, HEAD - ESTABLISHED BRANDS Rowland Thomas Andrew was granted 6,021 shares and covered exercise/tax liability with 628 shares, increasing direct ownership by 14% to 43,502 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- HEAD OF RARE DISEASE Mutz Christopher was granted 21,306 shares and covered exercise/tax liability with 2,221 shares, increasing direct ownership by 22% to 103,925 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- PRESIDENT & CEO Lalwani Nikhil was granted 75,592 shares and covered exercise/tax liability with 12,217 shares, increasing direct ownership by 18% to 421,949 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, GENERICS Gutwerg Ori was granted 12,969 shares and covered exercise/tax liability with 2,221 shares, increasing direct ownership by 14% to 86,842 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP - CORP. DEV. & STRATEGY Gassert Chad was granted 11,116 shares and covered exercise/tax liability with 2,221 shares, increasing direct ownership by 13% to 74,916 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, CHIEF HR OFFICER Davis Krista was granted 10,810 shares and covered exercise/tax liability with 1,555 shares, increasing direct ownership by 19% to 58,518 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SR. VP, GENERAL COUNSEL & SEC. Cook Meredith was granted 13,895 shares and covered exercise/tax liability with 1,555 shares, increasing direct ownership by 18% to 79,890 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP & CFO Carey Stephen P. was granted 22,233 shares and covered exercise/tax liability with 2,773 shares, increasing direct ownership by 11% to 189,543 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- HEAD OF RARE DISEASE Mutz Christopher sold $415,300 worth of shares (5,323 units at $78.02), decreasing direct ownership by 6% to 84,840 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, CHIEF HR OFFICER Davis Krista sold $296,495 worth of shares (3,814 units at $77.74), decreasing direct ownership by 7% to 49,263 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, HEAD - ESTABLISHED BRANDS Rowland Thomas Andrew covered exercise/tax liability with 1,051 shares, decreasing direct ownership by 3% to 38,109 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- HEAD OF RARE DISEASE Mutz Christopher covered exercise/tax liability with 5,576 shares and sold $538,300 worth of shares (7,032 units at $76.55), decreasing direct ownership by 12% to 90,163 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- PRESIDENT & CEO Lalwani Nikhil covered exercise/tax liability with 21,986 shares, decreasing direct ownership by 6% to 358,574 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, GENERICS Gutwerg Ori covered exercise/tax liability with 3,663 shares, decreasing direct ownership by 5% to 76,094 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP - CORP. DEV. & STRATEGY Gassert Chad covered exercise/tax liability with 3,325 shares, decreasing direct ownership by 5% to 66,021 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)
- SVP, CHIEF HR OFFICER Davis Krista covered exercise/tax liability with 2,470 shares, decreasing direct ownership by 4% to 53,077 units (SEC Form 4)4 - ANI PHARMACEUTICALS INC (0001023024) (Issuer)